Dr. Al Jurdi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2002 Holcombe Blvd
# Mhcl
Houston, TX 77030Phone+1 731-794-8709Fax+1 346-701-5261
Education & Training
- Baylor College of MedicineResidency, Psychiatry, 1999 - 2003
- American University of Beirut Faculty of MedicineClass of 1998
Certifications & Licensure
- TX State Medical License 2004 - 2026
- CO State Medical License 2021 - 2025
- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 16 citationsIdentification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.Marijn Lijffijt, Nicholas Murphy, Sidra Iqbal, Charles Green, Tabish Iqbal
Neuropsychopharmacology. 2021-11-27 - 7 citationsBayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depressionBrittany O'Brien, Charles Green, Rayan K. Aljurdi, Lee Chang, Marijn Lijffijt
Contemporary Clinical Trials Communications. 2019-08-21 - GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.Robert C. Young, Benoit H. Mulsant, Martha Sajatovic, Ariel G. Gildengers, Laszlo Gyulai
Focus. 2019-07-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: